Biktarvy, formally known as biktarvy, represents a potent single-tablet therapy for managing HIV infection. This medication unites three key antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the the viral ability to copy within the body, remarkably decreasing the viral quantity. For many individuals